|

Upcoming Articles:
Contents

Long-term Response to Galantamine in Relation to Short-term
Efficacy Data: Pooled Analysis in Patients with Mild to Moderate
Alzheimer’s Disease
Kavanagh S, Howe I, Brashear HR, Wang D, Baelen BV, Todd M,
Schwalen S
Apo-Eε4
allele in conjunction with Aβ42
and tau in CSF: Biomarker for Alzheimer’s Disease.
Kandimalla RJL, Prabhakar S, Binukumar BK, Wani WY, Gupta
N, Sharma D, Sunkaria A, Grover VK, Bhardwaj N, Jain K, Gill
KD
Correlation analysis of capillary APOE, VEGF and eNOS
expression in Alzheimer brains
Provias J, Jeynes B
EHT0202 in Alzheimer’s Disease: a 3-month, Randomized,
Placebo-controlled, Double-blind Study
Vellas B, Sol O, Snyder PJ, Ousset P-J, Haddad
R, Maurin M, Lemarié J-C, Désiré L, Pando
MP, and on behalf of EHT0202/002 study group
Neuronal Membranes are Key to the Pathogenesis of
Alzheimer's Disease: the Role of Both Raft and Non-Raft Membrane
Domains
Sutherland C
Cholesterol and LDL Relate to Neuritic Plaques and
to APOE4 Presence but Not to Neurofibrillary Tangles
Lesser GT, Beeri MS, Schmeidler J, Purohit DP, Haroutunian
V
Changes in the Expression of the Alzheimer’s
Disease-Associated Presenilin Gene in Drosophila Heart Leads
to Cardiac Dysfunction
Li A, Zhou C, Moore J, Zhang P, Tsai T-H,
Lee H-C, Romano DM, McKee ML, Schoenfeld DA, Serra MJ, Raygor
K, Cantiello HF, Fujimoto JG, Tanzi RE
Psychometric Comparison of Standard and Computerized
Administration of the Alzheimer’s Disease Assessment
Scale – Cognitive Subscale (ADASCog)
O'Halloran JP, Kemp AS, Salmon DP, Tariot PN, Schneider
LS
Errors in ADAS-Cog Administration and Scoring May
Undermine Clinical Trials Results
Schafer K, De Santi S, Schneider LS
Impaired Neural Transmission and Synaptic Plasticity
in Superior Cervical Ganglia from beta-Amyloid Rat Model of
Alzheimer’s Disease
Alzoubi KH, Alhaider IA, Tran TT, Mosely A, Alkadhi KA
Tolfenamic Acid Interrupts the De Novo Synthesis of
the beta-Amyloid Precursor Protein and Lowers Amyloid Beta
Via a Transcriptional Pathway
Adwan LI, Basha R, Abdelrahim M, Subaiea GM, Zawia NH
Amyloid ß
Peptide Levels Increase in Brain of AßPP
Swedish Mice after Exposure to Chlorpyrifos
Salaza JG, Ribes D, Cabré M, Domingo JL, Sanchez-Santed
F, María Colomina T
The mechanism of memory impairment induced by Aβ
chronic administration involves imbalance between cytokines
and neurotrophins in the rat hippocampus
Ji C, Song C, Zuo P
Mitochondria: the common upstream driver of amyloid-beta
and tau pathology in Alzheimer´s disease
Silva DFF, Esteves AR, Oliveira CR, Cardoso SM
How should we deal with missing data in clinical trials
involving Alzheimer's disease patients?
Coley N, Gardette V, Cantet C, Gillette-Guyonnet S ,
Nourhashemi F, Vellas B, Andrieu S
The potential dual effects of anesthetic isoflurane
on Aβ-induced
apoptosis
Xu Z, Dong Y, Wu X, Zhang J, McAuliffe S, Pan
C, Zhang Y, Ichinose F, Yue Y , Xie Z
Rosiglitazone does not improve cognition or global
function when used as adjunctive therapy to AChE inhibitors
in mild-to-moderate Alzheimer's disease: Two phase 3 studies
Harrington C, Sawchak S, Chiang C, Davies J, Donovan C,
Saunders AM, Irizarry M, Jeter B, Zvartau-Hind M, Van Dyck
CH, Gold M
Aβ
Oligomers Induce Glutamate Release from Hippocampal Neurons
Brito-Moreira J, Paula-Lima AC , Bomfim TR., Oliveira
FF, Sepúlveda FJ, De Mello FG, Aguayo LG, Panizzutti
R, Ferreira ST
Simvastatin and Other HMG-CoA Reductase Inhibitors
on Brain Cholesterol Levels in Alzheimer’s Disease
Longenberger J, Shah ZA
Chronic infusion of amyloid-β peptide and sustained attention altered α 7 nicotinic receptor density in the rat brain
Viel TA, Caetano AL, Albuquerque MS, Araujo MS and Buck HS
Multi-target inhibitors for proteins associated with Alzheimer: In silico discovery using fragment-based descriptors
Speck-Planche A, Kleandrova VV , Luan F, Natália M and Cordeiro DS
Magnetic resonance imaging in Alzheimer’s disease: from diagnosis to monitoring treatment effect
Filippi M, Agosta F, Frisoni GB, De Stefano N, Bizzi A, Bozzali M, Falini A, Rocca MA, Sorbi S, Caltagirone C and Tedeschi G
Pretreatment with memantine prevents Alzheimer-like alterations induced
by intrahippocampal okadaic acid administration in rats
Zimmer ER, Kalinine E, Haas CB, Torrez VR, Souza DO, Muller AP and Portela LV
The Effects of Cognitive Speed of Processing Training among Older Adults with Psychometrically- Defined Mild Cognitive Impairment
Valdés EG, O’Connor ML and Edwards JD
|